Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer

Publication Date: January 24, 2024
Last Updated: February 2, 2024

GUIDELINE STATEMENTS

Diagnosis

1. At the time of resection of suspected bladder cancer, a clinician should perform a thorough cystoscopic examination of a patient’s entire urethra and bladder that evaluates and documents tumor size, location, configuration, number, and mucosal mabnormalities.

(Clinical Principle, )
322859

2. At initial diagnosis of a patient with bladder cancer, a clinician should perform complete visual resection of the bladder tumor(s), when technically feasible.

(Clinical Principle, )
322859

3. A clinician should perform upper urinary tract imaging as a component of the initial evaluation of a patient with bladder cancer.

(Clinical Principle, )
322859

4. In a patient with a history of NMIBC with normal cystoscopy and positive cytology, a clinician should consider prostatic urethral biopsies and upper tract imaging, as well as enhanced cystoscopic techniques (blue light cystoscopy, when available), ureteroscopy, or random bladder biopsies.

(Expert Opinion, )
322859

Overview

Title

Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer

Authoring Organizations

American Urological Association

Society of Urologic Oncology